Omar N. Ammash

omar.ammash@lw.com

+1.312.777.7149

Emerging Companies & Growth

Profile

Omar Ammash represents US and international-based startups, emerging growth companies, and venture capital investors involved in technology, life sciences, and other growth industries.

Omar advises clients on a full range of transactions and general corporate matters, including:

Venture capital financings
Corporate governance
Mergers and acquisitions
Day-to-day corporate advice
Early-stage formation and strategy

While attending law school, he was a member of the Corporate Lab, a transactional-focused clinic, working on cutting-edge projects with multinational companies.

Experience

Representative transactions include:

Startup and Emerging Growth Company Financings

Rivian on multiple venture capital financings
Celestial AI on multiple venture capital financings
Sleeper on its US$50m Series C fundraise
GT Medical Technologies on its Series C fundraise
Novasenta on multiple venture capital financings
Homie Technology on multiple venture capital financings
Fluid Truck on its Series B fundraise
Jetti Resources on multiple venture capital financings
ActiveCampaign on its US$240 million Series C financing

Venture Capital Investments

Goldman Sachs on various lead investments, including in Nested Therapeutics and TORL Biotherapeutics
DNS Capital on various lead investments and follow-on growth financings for its portfolio companies
Drive Capital on various lead investments and follow-on growth financings for its portfolio companies
GreatPoint Ventures on various lead investments and follow-on growth financings for its portfolio companies
Sea Capital in its investment in Forte’s US$725m Series B round
Cadence Design Systems in multiple strategic investments
Softbank on various lead investments, including in Forward Health, Sprout Therapy and M1 Finance

Mergers, Acquisitions, and Capital Markets Transactions

Tegus on its acquisition of Canalyst
GTCR on its sale of Inteliquent to Sinch
Castle Creek on multiple portfolio company acquisitions, including its acquisition of Novavita
Henkel on its acquisition of Momentive’s consumer sealants division
Blaize on its business combination with BurTech Acquisition Corp.
Oscar Health on its US$1.4 billion IPO
Aon on its US$80 billion merger of equals with Willis towers (terminated)
Carlyle on its acquisition of Apollo Aviation